ST8SIA3 was proved to participate in the synthesis of A2B5 epitope and was critical for A2B5 immunoreactivity in glioblastoma, indicating the potential of neuraminidase treatment [53]. The gene discussed is ST8SIA3; the disease is glioblastoma.